Wealth Preservation Advisors’s Ginkgo Bioworks DNA Stock Holding History

Wealth Preservation Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50	Closed	-$307	–	314
2026 Q1	$307	Hold	50	–	–	﹤0.01%	837
2025 Q4	$416	Hold	50	–	–	﹤0.01%	580
2025 Q3	$729	Hold	50	–	–	﹤0.01%	547
2025 Q2	$563	Hold	50	–	–	﹤0.01%	549
2025 Q1	$285	Buy	+50	New	+$509	﹤0.01%	540

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Wealth Preservation Advisors's DNA Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Ginkgo Bioworks (DNA) in Q2 2026, closing a stake of 50 shares — an estimated $307 sold.

Wealth Preservation Advisors first reported a position in DNA in Q1 2025 and held it in 5 quarters. The position peaked at $729 in Q3 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Wealth Preservation Advisors reported no remaining Ginkgo Bioworks position as of Q2 2026 after selling out during the quarter.
Wealth Preservation Advisors sold 50 Ginkgo Bioworks shares in Q2 2026, an estimated $307.
Wealth Preservation Advisors first reported a position in Ginkgo Bioworks in Q1 2025 and held it in 5 quarters.
Wealth Preservation Advisors's Ginkgo Bioworks position peaked at $729 in Q3 2025.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.